Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

NCT05414500 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous T Cell Lymphoma
Mycosis Fungoides

Interventions

DRUG: Mogamulizumab
DRUG: Brentuximab vedotin

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]